Yi-Yi Wang

No ORCID on file · 5 papers in corpus · active 2021

Study types

  • article 4
  • other 1

Condition tags

  • adenomyosis 5
  • dysmenorrhea 1
other 2021
BioMed research international ·doi:10.1155/2021/8868700

Several theories on the origin of adenomyosis (ADS) have been proposed, of which the most widely accepted is the fundamental pathogenic role of uterine eutopic endometrium. Emerging evidence suggests that circular RNAs participate in the mu…

article 2021
Molecular medicine reports ·doi:10.3892/mmr.2021.11976

The estrogen 17β‑estradiol has been proven to serve an indispensable role in the occurrence and development of adenomyosis (ADS). The let‑7a/Lin28B axis can control cell proliferation by acting as a tumor‑inhibiting axis in numerous types o…

article 2021
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-020-00444-8
article 2021
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00753-w

BACKGROUND: Let-7a is a small non-coding RNA that has been found to take part in cell proliferation and apoptosis. The hippo-YAP1 axis, known as a tumour suppressor pathway, also plays an important role in cell proliferation and apoptosis. …

article 2021
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00756-7

Abstract Adenomyosis (ADS) is an estrogen-dependent gynecological disease with unspecified etiopathogenesis. Local hyperestrogenism may serve a key role in contributing to the origin of ADS. Talin1 is mostly identified to be overexpressed a…